Elderly patients with glioblastoma: state of the art

Bulletin du cancer
Julian BiauPierre Verrelle

Abstract

The incidence of glioblastoma increases with age, with a median age, at diagnosis, of 65 years. Indeed, the optimization of standard of care of elderly glioblastoma patients in an aging population in Western countries becomes crucial. The age remains the main prognostic factor of glioblastoma. Survival among elderly patients is significantly less than among younger patients. The median survival of elderly glioblastoma patients is generally inferior to 6 months. More aggressive tumor behavior, less aggressive treatments, increased toxicity of therapies and more unfavorable clinical factors and comorbidities could explain a higher severity of the disease in the elderly. The balance between treatment efficacy and quality of life is a major focus because of the shorter life expectancy of patients. The standard of care of glioblastoma in elderly patients remains controversial. Large optimal resection, when achievable, should be preferred to biopsy. Survival is longer after adjuvant radiotherapy, either normofractionated over 6-weeks course or hypofractionated over 3-weeks course, for patients with good clinical status. Hypofractionation is often preferred because of shorter procedure. Chemotherapy alone with temozolomide can be prop...Continue Reading

References

Jul 1, 1994·International Journal of Radiation Oncology, Biology, Physics·G S BaumanJ G Cairncross
Jul 8, 2000·The Oncologist·L Balducci, M Extermann
Jan 25, 2003·Acta neurochirurgica·V VuorinenJ Jääskeläinen
Mar 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W RoaP Forsyth
May 12, 2005·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Corrie A M MarijnenEd M Noordijk
Jun 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·René-Olivier MirimanoffRoger Stupp
Jul 10, 2007·Acta Neuropathologica·David N LouisPaul Kleihues
Jul 13, 2007·The New England Journal of Medicine·Stephen Hanna
Oct 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James J VredenburghHenry S Friedman
Sep 6, 2008·Science·D Williams ParsonsKenneth W Kinzler
Oct 24, 2008·The New England Journal of Medicine·Bruce R Bistrian
Sep 2, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Henry S FriedmanTimothy Cloughesy
May 21, 2010·International Journal of Epidemiology·UNKNOWN INTERPHONE Study Group
Sep 28, 2010·Neuro-Chirurgie·P Menei, P Metellus
Sep 28, 2010·Neuro-Chirurgie·I BaldiH Loiseau
Jun 29, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jaime Gállego Pérez-LarrayaJean-Yves Delattre
Sep 3, 2011·Revue neurologique·M RossettoM Sanson
Feb 1, 2012·Cancer Treatment Reviews·Cyrus ChargariJean-Jacques Mazeron
Apr 19, 2012·Lancet·Damien RicardJean-Yves Delattre
May 15, 2012·The Lancet Oncology·Wolfgang WickUNKNOWN NOA-08 Study Group of Neuro-oncology Working Group (NOA) of German Cancer Society
Dec 5, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hiroko Ohgaki, Paul Kleihues
Dec 15, 2012·Cancer Genetics·McKinsey L Goodenberger, Robert B Jenkins
Apr 19, 2013·Neuro-oncology·Benedikt WiestlerUNKNOWN Neuro-oncology Working Group (NOA) of the German Cancer Society
Nov 12, 2013·Journal of Neurosurgery·Abraham NoorbakhshClark C Chen
Feb 21, 2014·The New England Journal of Medicine·Mark R GilbertMinesh P Mehta
Feb 21, 2014·The New England Journal of Medicine·Olivier L ChinotTimothy Cloughesy
May 6, 2014·Neuro-oncology·Luc BauchetLuc Taillandier
May 21, 2014·Neuro-oncology·Quinn T OstromJill S Barnholtz-Sloan

❮ Previous
Next ❯

Citations

Jan 19, 2019·Future Oncology·Veronica VillaniAndrea Pace
Dec 22, 2016·CNS Oncology·Jean-Aine PretanvilDavid E Piccioni
Aug 20, 2019·Journal of Neuro-oncology·Menha SwellamSamy B Said
Jul 19, 2018·Radiology and Oncology·Uros SmrdelAles Smrdel

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.